About Us 2019-02-11T15:27:32+00:00

WHO WE ARE

The professionals at Gilmartin Group have earned reputations as leaders in strategic advisory roles. Whether you are an early stage private company or a publicly traded entity with a multi-billion dollar market cap – or something in between – we will partner with you to drive success. Collectively, the members of our team have developed, launched and supported investor relations initiatives for more than 100 companies, including many of the best-known and top-performing IPOs.

Our team is comprised of Wall Street and IR veterans who have extensive relationships with analysts, investment bankers, institutional investors, and the venture community through years of personal interaction and strong execution. With deep knowledge of the healthcare industry and capital markets, our tight-knit team focuses on a select group of clients to ensure senior level attention and deliver strategic value. With this, we provide our clients a competitive advantage.

Our Culture. We thrive on challenge and hustle. Life isn’t perfect, but we jump to action and make the best of each situation – we have fun and want to win.

OUR TEAM

LYNN PIEPER LEWIS

Founder & Chief Executive Officer

GREG CHODACZEK

Managing Director

DEBBIE KASTER

Managing Director

LEIGH SALVO

Managing Director

LAURENCE WATTS

Managing Director

CARRIE MENDIVIL

Principal

PHILIP TAYLOR

Associate

HUNTER CABI

Analyst

AUDREY GIBSON

Analyst

VIVIAN ROQUE

Analyst

TOM BRENNAN

Chief Financial Officer

BEATA SERAFINI

Office Manager & Marketing Specialist

BAILEY

Dog

PHILANTHROPY

“From what we get, we can make a living;
what we give, however, makes a life.”
~Arthur Ashe

At Gilmartin Group, we are grateful for the opportunity to spend our days doing what we love – challenging and rewarding work with industry-leading companies. We pride ourselves on teamwork, accountability and our commitment to enrichment. Through financial and service-oriented support of the organizations below, we are giving back to our community and supporting continued research and access to healthcare.